 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Cytokine
|
 |
|
Title:
|
 |
Human interleukin-6, nmr, 32 structures
|
|
Structure:
|
 |
Interleukin-6. Chain: a. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
NMR struc:
|
 |
32 models
|
 |
|
Authors:
|
 |
G.Y.Xu,H.A.Yu,J.Hong,M.Stahl,T.Mcdonagh,L.E.Kay,D.A.Cumming
|
Key ref:
|
 |
G.Y.Xu
et al.
(1997).
Solution structure of recombinant human interleukin-6.
J Mol Biol,
268,
468-481.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
31-Jan-97
|
Release date:
|
04-Feb-98
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
P05231
(IL6_HUMAN) -
Interleukin-6
|
|
|
|
Seq: Struc:
|
 |
 |
 |
212 a.a.
166 a.a.
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
1 term
|
 |
|
Biological process
|
immune response
|
1 term
|
 |
|
Biochemical function
|
cytokine activity
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
268:468-481
(1997)
|
|
PubMed id:
|
|
|
|
|
| |
|
Solution structure of recombinant human interleukin-6.
|
|
G.Y.Xu,
H.A.Yu,
J.Hong,
M.Stahl,
T.McDonagh,
L.E.Kay,
D.A.Cumming.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Interleukin-6 (IL-6) is a 185 amino acid cytokine which exerts multiple
biological effects in vivo and whose dysregulation underlies several disease
processes. The solution structure of recombinant human interleukin-6 has now
been determined using heteronuclear three and four-dimensional NMR spectroscopy.
The structure of the molecule was determined using 3044 distance and torsion
restraints derived by NMR spectroscopy to generate an ensemble of 32 structures
using a combined distance geometry/simulated annealing protocol. The protein
contains five alpha-helices interspersed with variable-length loops; four of
these helices constitute a classical four-helix bundle with the fifth helix
located in the CD loop. There were no distance violations greater than 0.3 A in
any of the final 32 structures and the ensemble has an average-to-the-mean
backbone root-mean-square deviation of 0.50 A for the core four-helix bundle.
Although the amino-terminal 19 amino acids are disordered in solution, the
remainder of the molecule has a well defined structure that shares many features
displayed by other long-chain four-helix bundle cytokines. The high-resolution
NMR structure of hIL-6 is used to rationalize available mutagenesis data in
terms of a heteromeric receptor complex.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Figure 3. Stereo image of the averaged and minimized NMR
structure of IL-6. Only residues 20 to 185 are shown and
individual helices are labeled.
|
 |
Figure 4.
Figure 4. Best-fit superposition of the C^α atoms of the
X-ray and the restrained minimized averaged NMR structures of
IL-6. (a) The color coding scheme is identical to that of Figure
1. The average minimized NMR structure is shown in thick lines
while the X-ray structure is shown in thin lines. (b) C^α-C^α
distances after the best-fit superposition.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(1997,
268,
468-481)
copyright 1997.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Sahoo,
and
S.H.Im
(2010).
Interleukin and interleukin receptor diversity: role of alternative splicing.
|
| |
Int Rev Immunol, 29,
77.
|
 |
|
|
|
|
 |
S.Yachamaneni,
G.Yushin,
S.H.Yeon,
Y.Gogotsi,
C.Howell,
S.Sandeman,
G.Phillips,
and
S.Mikhalovsky
(2010).
Mesoporous carbide-derived carbon for cytokine removal from blood plasma.
|
| |
Biomaterials, 31,
4789-4794.
|
 |
|
|
|
|
 |
O.Hecht,
A.J.Dingley,
A.Schwanter,
S.Ozbek,
S.Rose-John,
and
J.Grötzinger
(2006).
The solution structure of the membrane-proximal cytokine receptor domain of the human interleukin-6 receptor.
|
| |
Biol Chem, 387,
1255-1259.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Hampel,
A.Haslinger,
M.Scheloske,
F.Padberg,
P.Fischer,
J.Unger,
S.J.Teipel,
M.Neumann,
C.Rosenberg,
R.Oshida,
C.Hulette,
D.Pongratz,
M.Ewers,
H.A.Kretzschmar,
and
H.J.Möller
(2005).
Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer's disease brain.
|
| |
Eur Arch Psychiatry Clin Neurosci, 255,
269-278.
|
 |
|
|
|
|
 |
A.Schwantner,
A.J.Dingley,
S.Ozbek,
S.Rose-John,
and
J.Grötzinger
(2004).
Direct determination of the interleukin-6 binding epitope of the interleukin-6 receptor by NMR spectroscopy.
|
| |
J Biol Chem, 279,
571-576.
|
 |
|
|
|
|
 |
K.W.Lynch
(2004).
Consequences of regulated pre-mRNA splicing in the immune system.
|
| |
Nat Rev Immunol, 4,
931-940.
|
 |
|
|
|
|
 |
S.Bosze,
F.Hudecz,
P.Igaz,
Z.Ortutay,
G.Csík,
A.Falus,
and
S.Tóth
(2003).
Interleukin-6 N-terminal peptides modulate the expression of junB protooncogene and the production of fibrinogen in HepG2 cells.
|
| |
Biol Chem, 384,
409-421.
|
 |
|
|
|
|
 |
T.M.Rose,
J.T.Ryan,
E.R.Schultz,
B.W.Raden,
and
C.C.Tsai
(2003).
Analysis of 4.3 kilobases of divergent locus B of macaque retroperitoneal fibromatosis-associated herpesvirus reveals a close similarity in gene sequence and genome organization to Kaposi's sarcoma-associated herpesvirus.
|
| |
J Virol, 77,
5084-5097.
|
 |
|
|
|
|
 |
C.Cebo,
V.Durier,
P.Lagant,
E.Maes,
D.Florea,
T.Lefebvre,
G.Strecker,
G.Vergoten,
and
J.P.Zanetta
(2002).
Function and molecular modeling of the interaction between human interleukin 6 and its HNK-1 oligosaccharide ligands.
|
| |
J Biol Chem, 277,
12246-12252.
|
 |
|
|
|
|
 |
J.N.Varghese,
R.L.Moritz,
M.Z.Lou,
A.Van Donkelaar,
H.Ji,
N.Ivancic,
K.M.Branson,
N.E.Hall,
and
R.J.Simpson
(2002).
Structure of the extracellular domains of the human interleukin-6 receptor alpha -chain.
|
| |
Proc Natl Acad Sci U S A, 99,
15959-15964.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.Yamada,
E.Suzuki,
and
K.Hirayama
(2002).
Identification of the interface of a large protein-protein complex using H/D exchange and Fourier transform ion cyclotron resonance mass spectrometry.
|
| |
Rapid Commun Mass Spectrom, 16,
293-299.
|
 |
|
|
|
|
 |
T.Taverner,
N.E.Hall,
R.A.O'Hair,
and
R.J.Simpson
(2002).
Characterization of an antagonist interleukin-6 dimer by stable isotope labeling, cross-linking, and mass spectrometry.
|
| |
J Biol Chem, 277,
46487-46492.
|
 |
|
|
|
|
 |
H.Mizuguchi,
H.Mizuno,
K.Yasukawa,
T.Ishiguro,
K.Fukui,
T.Imanaka,
and
M.Takagi
(2001).
Enhanced signal transduction by a directly fused protein of interleukin-6 and its receptor.
|
| |
J Biosci Bioeng, 91,
299-304.
|
 |
|
|
|
|
 |
P.Igaz,
S.Bösze,
S.Tóth,
A.Falus,
and
F.Hudecz
(2001).
C-terminal peptides of interleukin-6 modulate the expression of junB protooncogene and the production of fibrinogen by HepG2 cells.
|
| |
Biol Chem, 382,
669-676.
|
 |
|
|
|
|
 |
T.Harada,
E.Kurimoto,
Y.Moriyama,
D.Ejima,
T.Sakai,
D.Nohara,
and
K.Kato
(2001).
Application of combined reagent solution to the oxidative refolding of recombinant human interleukin 6.
|
| |
Chem Pharm Bull (Tokyo), 49,
1128-1131.
|
 |
|
|
|
|
 |
J.Bravo,
and
J.K.Heath
(2000).
Receptor recognition by gp130 cytokines.
|
| |
EMBO J, 19,
2399-2411.
|
 |
|
|
|
|
 |
J.Feng,
Y.Ren,
and
B.Shen
(2000).
Prediction on the binding domain between human interleukin-6 and its receptor.
|
| |
Sci China C Life Sci, 43,
409-417.
|
 |
|
|
|
|
 |
J.M.Matthews,
R.S.Norton,
A.Hammacher,
and
R.J.Simpson
(2000).
The single mutation Phe173 --> Ala induces a molten globule-like state in murine interleukin-6.
|
| |
Biochemistry, 39,
1942-1950.
|
 |
|
|
|
|
 |
M.C.Deller,
K.R.Hudson,
S.Ikemizu,
J.Bravo,
E.Y.Jones,
and
J.K.Heath
(2000).
Crystal structure and functional dissection of the cytostatic cytokine oncostatin M.
|
| |
Structure, 8,
863-874.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.H.Hoischen,
P.Vollmer,
P.März,
S.Ozbek,
K.S.Götze,
C.Peschel,
T.Jostock,
T.Geib,
J.Müllberg,
S.Mechtersheimer,
M.Fischer,
J.Grötzinger,
P.R.Galle,
and
S.Rose-John
(2000).
Human herpes virus 8 interleukin-6 homologue triggers gp130 on neuronal and hematopoietic cells.
|
| |
Eur J Biochem, 267,
3604-3612.
|
 |
|
|
|
|
 |
J.Grötzinger,
T.Kernebeck,
K.J.Kallen,
and
S.Rose-John
(1999).
IL-6 type cytokine receptor complexes: hexamer, tetramer or both?
|
| |
Biol Chem, 380,
803-813.
|
 |
|
|
|
|
 |
K.J.Kallen,
J.Grötzinger,
E.Lelièvre,
P.Vollmer,
D.Aasland,
C.Renné,
J.Müllberg,
K.H.Myer zum Büschenfelde,
H.Gascan,
and
S.Rose-John
(1999).
Receptor recognition sites of cytokines are organized as exchangeable modules. Transfer of the leukemia inhibitory factor receptor-binding site from ciliary neurotrophic factor to interleukin-6.
|
| |
J Biol Chem, 274,
11859-11867.
|
 |
|
|
|
|
 |
R.A.Gadient,
and
P.H.Patterson
(1999).
Leukemia inhibitory factor, Interleukin 6, and other cytokines using the GP130 transducing receptor: roles in inflammation and injury.
|
| |
Stem Cells, 17,
127-137.
|
 |
|
|
|
|
 |
C.Renné,
K.J.Kallen,
J.Müllberg,
T.Jostock,
J.Grötzinger,
and
S.Rose-John
(1998).
A new type of cytokine receptor antagonist directly targeting gp130.
|
| |
J Biol Chem, 273,
27213-27219.
|
 |
|
|
|
|
 |
J.Bravo,
D.Staunton,
J.K.Heath,
and
E.Y.Jones
(1998).
Crystal structure of a cytokine-binding region of gp130.
|
| |
EMBO J, 17,
1665-1674.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.C.Cheetham,
D.M.Smith,
K.H.Aoki,
J.L.Stevenson,
T.J.Hoeffel,
R.S.Syed,
J.Egrie,
and
T.S.Harvey
(1998).
NMR structure of human erythropoietin and a comparison with its receptor bound conformation.
|
| |
Nat Struct Biol, 5,
861-866.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.M.Matthews,
A.Hammacher,
G.J.Howlett,
and
R.J.Simpson
(1998).
Physicochemical characterization of an antagonistic human interleukin-6 dimer.
|
| |
Biochemistry, 37,
10671-10680.
|
 |
|
|
|
|
 |
M.G.Hinds,
T.Maurer,
J.G.Zhang,
N.A.Nicola,
and
R.S.Norton
(1998).
Solution structure of leukemia inhibitory factor.
|
| |
J Biol Chem, 273,
13738-13745.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.J.Duhé,
G.A.Evans,
R.A.Erwin,
R.A.Kirken,
G.W.Cox,
and
W.L.Farrar
(1998).
Nitric oxide and thiol redox regulation of Janus kinase activity.
|
| |
Proc Natl Acad Sci U S A, 95,
126-131.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|